Effect of the novel oral dipeptidyl peptidase IV inhibitor vildagliptin on the pharmacokinetics and pharmacodynamics of warfarin in healthy subjects

Author: He Yan-Ling   Sabo Ron   Riviere Gilles-Jacques   Sunkara Gangadhar   Leon Selene   Ligueros-Saylan Monica   Rosenberg Mitchell   Dole William P.   Howard Dan  

Publisher: Informa Healthcare

ISSN: 1473-4877

Source: Current Medical Research and Opinion, Vol.23, Iss.5, 2007-05, pp. : 1131-1138

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content